Chemoinformaics analysis of 5-Methoxy-N-methyltryptamine
| Molecular Weight | 204.273 | nRot | 4 |
| Heavy Atom Molecular Weight | 188.145 | nRig | 10 |
| Exact Molecular Weight | 204.126 | nRing | 2 |
| Solubility: LogS | -1.416 | nHRing | 1 |
| Solubility: LogP | 1.827 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 33.7107 |
| nHD | 2 | BPOL | 18.9273 |
| QED | 0.798 |
| Synth | 1.975 |
| Natural Product Likeliness | -0.03 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.488 |
| HIA | 0.005 |
| CACO-2 | -4.756 |
| MDCK | 0.00000762 |
| BBB | 0.839 |
| PPB | 0.301843 |
| VDSS | 3.084 |
| FU | 0.591347 |
| CYP1A2-inh | 0.603 |
| CYP1A2-sub | 0.948 |
| CYP2c19-inh | 0.079 |
| CYP2c19-sub | 0.739 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.873 |
| CYP2d6-inh | 0.866 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.22 |
| CL | 8.037 |
| T12 | 0.709 |
| hERG | 0.346 |
| Ames | 0.146 |
| ROA | 0.831 |
| SkinSen | 0.918 |
| Carcinogencity | 0.031 |
| EI | 0.048 |
| Respiratory | 0.97 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.629278 |